Assessment of the INVOcell Intravaginal Culture System
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kevin Doody, MD
INVO Bioscience, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Piedmont Reproductive Endocrinology Group
Greenville, South Carolina, United States
- Piedmont Reproductive Endocrinology Group
West Columbia, South Carolina, United States
- Fertility Center of San Antonio
San Antonio, Texas, United States
- the New Hope Center for Reproductive Medicine
Virginia Beach, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2020
- Primary completion
- 31 Jul 2021
- Completion
- 31 Mar 2022
- Last update posted
- 28 Jul 2020
- Registered enrollment
- 180
- Registry id
- NCT04246268
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.